Alzheimer's Association International Conference

Marwan Sabbagh, MD: Observations From AAIC 2020

September 01, 2020

The director of the Lou Ruvo Center for Brain Health and neurologist at Cleveland Clinic detailed the state of Alzheimer disease and what research particularly grabbed his attention at AAIC 2020.

Katrina Celis, MD: Genetics and Their Role in Alzheimer Research, Clinical Care

August 12, 2020

The postdoctoral fellow at the University of Miami Miller School of Medicine detailed the role that increased APOE ε4 expression can have on future research and clinical care.

Q&A: Genetic Ancestry and Alzheimer Disease Risk

August 06, 2020

Katrina Celis, MD, a postdoctoral fellow at the University of Miami Miller School of Medicine, discussed how ancestral genetics can play a key role in Alzheimer disease risk.

Sargramostim Shows Safety and Promise as Potential Alzheimer Treatment

August 06, 2020

The investigators wrote that the Alzheimer’s Association “Part the Cloud” funded 24-week treatment trial is now warranted after sargramostim showed a safe and tolerable profile.

Dementia-Related Psychosis Places Heavy Burden on Patients and Caretakers

August 05, 2020

Data from 2 posters presented at AAIC 2020 suggest that there is an unmet need for safe and effective treatments for patients who experience dementia-related psychosis.

Raymond S. Turner, MD, PhD: Safety Results for Nilotinib in Alzheimer

August 05, 2020

The director of the Memory Disorders Program and professor of neurology at Georgetown University Medical Center detailed the phase 2 study findings of nilotinib in patients with Alzheimer disease.